2019
DOI: 10.1111/jnc.14669
|View full text |Cite
|
Sign up to set email alerts
|

FipoQ/FBXO33, a Cullin‐1‐based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein

Abstract: Polyglutamine (polyQ) diseases describe a group of progressive neurodegenerative disorders caused by the CAG triplet repeat expansion in the coding region of the disease genes. To date, nine such diseases, including spinocerebellar ataxia type 3 (SCA3), have been reported. The formation of SDS‐insoluble protein aggregates in neurons causes cellular dysfunctions, such as impairment of the ubiquitin‐proteasome system, and contributes to polyQ pathologies. Recently, the E3 ubiquitin ligases, which govern substrat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 68 publications
0
11
0
Order By: Relevance
“…Mutations in the F box protein FBXO7 (encoded by PARK15 ), for example, have been shown to give rise to early-onset autosomal recessive Parkinson's disease ( Shojaee et al., 2008 ), and SCF FBXL5 has been found to catalyze ubiquitylation of α-synuclein, which contributes to the Lewy body-like pathology of Parkinson's disease ( Gerez et al., 2019 ). In addition, down-regulation of CUL1 and SKP1 has been observed in animal models of Huntington's disease and spinocerebellar ataxia type 3 (SCA3) ( Bhutani et al., 2012 ), and SCF FBXO33 modulates the ubiquitylation and solubility of the polyglutamine protein SCA3 ( Chen et al., 2019 ). However, no biological data have been available on the potential role of SCF-type ubiquitin ligases in the pathogenesis of ALS.…”
Section: Discussionmentioning
confidence: 99%
“…Mutations in the F box protein FBXO7 (encoded by PARK15 ), for example, have been shown to give rise to early-onset autosomal recessive Parkinson's disease ( Shojaee et al., 2008 ), and SCF FBXL5 has been found to catalyze ubiquitylation of α-synuclein, which contributes to the Lewy body-like pathology of Parkinson's disease ( Gerez et al., 2019 ). In addition, down-regulation of CUL1 and SKP1 has been observed in animal models of Huntington's disease and spinocerebellar ataxia type 3 (SCA3) ( Bhutani et al., 2012 ), and SCF FBXO33 modulates the ubiquitylation and solubility of the polyglutamine protein SCA3 ( Chen et al., 2019 ). However, no biological data have been available on the potential role of SCF-type ubiquitin ligases in the pathogenesis of ALS.…”
Section: Discussionmentioning
confidence: 99%
“…Healthcare records contain a lot of missing values which imposes difficulties for researchers who plan to model these datasets. Clinical datasets, especially for laboratory measurements, and imaging records often contain missing values [ 45 ]. These shortcomings bring difficulties to capture the patterns in clinical datasets.…”
Section: Discussionmentioning
confidence: 99%
“…Given their antioxidant capabilities, we next tested if our LCC and lignin preparations would elicit any effect on modifying polyQ protein aggregation. A polyQ disease cell model was established with the overexpression of SCA type3 (SCA3) disease protein ATXN3Q71 (Ataxin-3 protein harboring 71 repeats of glutamine) in a human neuroblastoma cell line SK-N-MC (Chen Z. S. et al, 2018;Chen et al, 2019). The percentage of cells with polyQ protein aggregates was used as readout to evaluate the protein aggregation-modulatory effects of LCCs and lignin.…”
Section: Effect Of Lcc and Lignin Preparations On Atxn3q71 Protein Agmentioning
confidence: 99%